Free Trial

Strs Ohio Acquires 11,002 Shares of Teleflex Incorporated $TFX

Teleflex logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Strs Ohio raised its stake in Teleflex by 47.7%, adding 11,002 shares to hold 34,058 shares (about 0.08% of the company) valued at $4.156 million at the end of the quarter.
  • Teleflex missed quarterly estimates, reporting EPS of $1.93 vs. $3.73 expected and revenue of $569M vs. $912.57M expected, with revenue down 28.5% YoY and a negative net margin of 30.56%; management set FY2026 guidance of $6.25–$6.55 EPS while analysts model roughly $6.77.
  • Institutional ownership is high at 95.62%; notable moves include AQR boosting its position 478.1% to 2,366,131 shares (~$287.6M) and Arrowstreet increasing holdings, while the stock trades with a negative PE (-5.87), $5.34B market cap, and an average analyst rating of "Hold" with a $133.57 target.
  • Five stocks to consider instead of Teleflex.

Strs Ohio raised its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 47.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 34,058 shares of the medical technology company's stock after acquiring an additional 11,002 shares during the quarter. Strs Ohio owned approximately 0.08% of Teleflex worth $4,156,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. AQR Capital Management LLC boosted its position in Teleflex by 478.1% during the third quarter. AQR Capital Management LLC now owns 2,366,131 shares of the medical technology company's stock valued at $287,603,000 after purchasing an additional 1,956,811 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Teleflex by 0.3% during the third quarter. Dimensional Fund Advisors LP now owns 1,245,614 shares of the medical technology company's stock valued at $152,408,000 after buying an additional 3,812 shares during the last quarter. Cooke & Bieler LP lifted its position in shares of Teleflex by 1.2% during the third quarter. Cooke & Bieler LP now owns 1,220,637 shares of the medical technology company's stock valued at $149,357,000 after buying an additional 14,673 shares during the last quarter. Abrams Bison Investments LLC bought a new stake in shares of Teleflex in the 3rd quarter valued at about $112,317,000. Finally, Arrowstreet Capital Limited Partnership boosted its holdings in shares of Teleflex by 123.9% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 660,800 shares of the medical technology company's stock valued at $80,855,000 after buying an additional 365,663 shares in the last quarter. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Stock Up 0.7%

TFX stock opened at $120.70 on Wednesday. The stock has a market capitalization of $5.34 billion, a PE ratio of -5.87, a price-to-earnings-growth ratio of 0.86 and a beta of 0.82. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67. The company has a quick ratio of 2.01, a current ratio of 2.54 and a debt-to-equity ratio of 0.81. The firm has a 50 day moving average of $118.84 and a 200 day moving average of $116.71.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings results on Thursday, February 26th. The medical technology company reported $1.93 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $3.73 by ($1.80). The company had revenue of $569.00 million for the quarter, compared to analyst estimates of $912.57 million. Teleflex had a negative net margin of 30.56% and a positive return on equity of 14.30%. The company's revenue for the quarter was down 28.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $3.89 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Sell-side analysts forecast that Teleflex Incorporated will post 6.77 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Friday, March 6th were paid a $0.34 dividend. The ex-dividend date was Friday, March 6th. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. Teleflex's dividend payout ratio (DPR) is -6.62%.

Analysts Set New Price Targets

Several research firms recently commented on TFX. Zacks Research upgraded shares of Teleflex from a "strong sell" rating to a "hold" rating in a research note on Tuesday, April 28th. Raymond James Financial upgraded shares of Teleflex from a "market perform" rating to an "outperform" rating and set a $128.00 target price for the company in a research note on Friday, March 27th. Needham & Company LLC lifted their price target on shares of Teleflex from $138.00 to $147.00 and gave the stock a "buy" rating in a report on Thursday, February 26th. Wells Fargo & Company upped their price target on Teleflex from $116.00 to $130.00 and gave the stock an "equal weight" rating in a research report on Friday, February 27th. Finally, Weiss Ratings reiterated a "sell (d)" rating on shares of Teleflex in a report on Friday, March 27th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $133.57.

Read Our Latest Stock Report on Teleflex

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company's offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Featured Articles

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Teleflex Right Now?

Before you consider Teleflex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.

While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines